Bogle Investment Management’s Haemonetics HAE Stock Holding History

Bogle Investment Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-37,688	Closed	-$3.29M	–	197
2020 Q3	$3.29M	Buy	+37,688	New	+$3.29M	0.96%	11
2020 Q2	–	Sell	-70,464	Closed	-$7.02M	–	357
2020 Q1	$7.02M	Buy	+70,464	New	+$7.64M	0.73%	64
2018 Q4	–	Sell	-17,278	Closed	-$1.98M	–	367
2018 Q3	$1.98M	Sell	17,278 -308	-2%	-$31.9K	0.14%	144
2018 Q2	$1.58M	Hold	17,586	–	–	0.11%	161
2018 Q1	$1.29M	Sell	17,586 -198,171	-92%	-$13.6M	0.1%	176
2017 Q4	$12.5M	Buy	215,757 +188,138	+681%	+$9.91M	0.92%	38
2017 Q3	$1.24M	Buy	+27,619	New	+$1.15M	0.08%	205
2017 Q1	–	Sell	-146,483	Closed	-$5.89M	–	333
2016 Q4	$5.89M	Sell	146,483 -96,109	-40%	-$3.62M	0.41%	92
2016 Q3	$8.78M	Sell	242,592 -107,971	-31%	-$3.71M	0.63%	59
2016 Q2	$10.2M	Buy	350,563 +173,038	+97%	+$5.23M	0.7%	50
2016 Q1	$6.21M	Buy	177,525 +119,822	+208%	+$3.87M	0.41%	83
2015 Q4	$1.86M	Buy	+57,703	New	+$1.87M	0.13%	203

Other funds holding HAE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bogle Investment Management's HAE Position: Q4 2020 in Review

Bogle Investment Management sold out of Haemonetics (HAE) in Q4 2020, closing a stake of 37,688 shares — an estimated $3.29M sold.

Bogle Investment Management first reported a position in HAE in Q4 2015 and held it in 12 quarters. The position peaked at $12.5M in Q4 2017. 286 funds tracked by Wall St. Rank hold HAE as of Q4 2020.

Bogle Investment Management reported no remaining Haemonetics position as of Q4 2020 after selling out during the quarter.
Bogle Investment Management sold 37,688 Haemonetics shares in Q4 2020, an estimated $3.29M.
Bogle Investment Management first reported a position in Haemonetics in Q4 2015 and held it in 12 quarters.
Bogle Investment Management's Haemonetics position peaked at $12.5M in Q4 2017.
286 funds tracked by Wall St. Rank held Haemonetics as of Q4 2020.

Based on Bogle Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.